WallStreetZen

NASDAQ: CLGN
CollPlant Biotechnologies Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CLGN

Based on 1 analysts offering 12 month price targets for CollPlant Biotechnologies Ltd.
Min Forecast
$26.00+47.81%
Avg Forecast
$26.00+47.81%
Max Forecast
$26.00+47.81%

Should I buy or sell CLGN stock?

Based on 1 analysts offering ratings for CollPlant Biotechnologies Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

CLGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 3%
98
BuyMaintains$26.00+47.81%2021-02-09

1 of 1

Forecast return on equity

Is CLGN forecast to generate an efficient return?
Company
75.65%
Industry
21.88%
Market
37.5%
CLGN's Return on Equity is forecast to be high in 3 years (75.65%); analysts are confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is CLGN forecast to generate an efficient return on assets?
Company
68.38%
Industry
6.66%
CLGN is forecast to generate higher Return on Assets (68.38%) than the US Biotechnology industry average (6.66%)
Forecast

CLGN earnings per share forecast

What is CLGN's earnings per share in the next 3 years based on estimates from 1 analysts?
Avg 1 year Forecast
$0.20+5.26%
Avg 2 year Forecast
$1.90+900%
Avg 3 year Forecast
$3.88+1,942.11%
CLGN's earnings are forecast to grow at an exceptional rate of 173.33% per year
Forecast

CLGN revenue forecast

What is CLGN's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$15.5M-2.47%
Avg 2 year Forecast
$49.2M+209.79%
Avg 3 year Forecast
$70.4M+343.23%
CLGN's revenue is forecast to grow at an exceptional rate of 64.26% per year
Forecast

CLGN earnings growth forecast

How is CLGN forecast to perform vs Biotechnology companies and vs the US market?
Company
173.33%
Industry
6.78%
Market
14.37%
CLGN's earnings are forecast to grow faster (173.33% per year) than the US Biotechnology industry average (6.78%)
Forecast
CLGN's earnings are forecast to grow faster (173.33% per year) than the US market average (14.37%)
Forecast
CLGN's earnings are forecast to grow faster (173.33% per year) than the risk-free savings rate (1.4%)
Forecast

CLGN revenue growth forecast

How is CLGN forecast to perform vs Biotechnology companies and vs the US market?
Company
64.26%
Industry
30.03%
Market
10.08%
CLGN's revenues are forecast to grow faster (64.26% per year) than the US Biotechnology industry average (30.03%)
Forecast
CLGN's revenues are forecast to grow faster (64.26% per year) than the US market average (10.08%)
Forecast

CollPlant Biotechnologies Ltd Stock Forecast FAQ

Is CollPlant Biotechnologies Ltd Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 1 Wall Street analysts covering (NASDAQ: CLGN) stock is to Buy CLGN stock.

Out of 1 analysts, 0 (0%) are recommending CLGN as a Strong Buy, 1 (100%) are recommending CLGN as a Buy, 0 (0%) are recommending CLGN as a Hold, 0 (0%) are recommending CLGN as a Sell, and 0 (0%) are recommending CLGN as a Strong Sell.

What is CLGN's earnings growth forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's forecast annual earnings growth rate of 173.33% is forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 6.78%, and and it is also forecast to beat the US market's average forecast earnings growth rate of 14.37%.

CollPlant Biotechnologies Ltd's earnings in 2021 is $1,104,000.On average, 1 Wall Street analysts forecast CLGN's earnings for 2021 to be $2,138,324, with the lowest CLGN earnings forecast at $2,138,324, and the highest CLGN earnings forecast at $2,138,324. On average, 2 Wall Street analysts forecast CLGN's earnings for 2022 to be $20,314,082, with the lowest CLGN earnings forecast at $19,138,003, and the highest CLGN earnings forecast at $21,490,160.

In 2023, CLGN is forecast to generate $41,483,493 in earnings, with the lowest earnings forecast at $5,131,979 and the highest earnings forecast at $77,835,008.

What is CLGN's revenue growth forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's forecast annual revenue growth rate of 64.26% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.03%, and and it is also forecast to beat the US market's average forecast revenue growth rate of 10.08%.

CollPlant Biotechnologies Ltd's revenue in 2021 is $15,888,000.On average, 2 Wall Street analysts forecast CLGN's revenue for 2021 to be $165,666,683, with the lowest CLGN revenue forecast at $162,405,738, and the highest CLGN revenue forecast at $168,927,628. On average, 2 Wall Street analysts forecast CLGN's revenue for 2022 to be $526,241,635, with the lowest CLGN revenue forecast at $451,186,448, and the highest CLGN revenue forecast at $601,296,821.

In 2023, CLGN is forecast to generate $752,904,021 in revenue, with the lowest revenue forecast at $250,504,703 and the highest revenue forecast at $1,255,303,339.

What is CLGN's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: CLGN) forecast ROA is 68.38%, which is higher than the forecast US Biotechnology industry average of 6.66%.

What is CLGN's Price Target?

According to 1 Wall Street analysts that have issued a 1 year CLGN price target, the average CLGN price target is $26.00, with the highest CLGN stock price forecast at $26.00 and the lowest CLGN stock price forecast at $26.00.

On average, Wall Street analysts predict that CollPlant Biotechnologies Ltd's share price could stay at $26.00 by Feb 9, 2022. The average CollPlant Biotechnologies Ltd stock price prediction forecasts a potential downside of N/A from the current CLGN share price of $17.59.

What is CLGN's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: CLGN) CollPlant Biotechnologies Ltd's current Earnings Per Share (EPS) is $0.19. On average, analysts forecast that CLGN's EPS will be $0.20 for 2021, with the lowest EPS forecast at $0.20, and the highest EPS forecast at $0.20. On average, analysts forecast that CLGN's EPS will be $1.90 for 2022, with the lowest EPS forecast at $1.79, and the highest EPS forecast at $2.01. In 2023, CLGN's EPS is forecast to hit $3.88 (min: $0.48, max: $7.28).

What is CLGN's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: CLGN) forecast ROE is 75.65%, which is considered strong.
©2021 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsContact
Stocks
Stock ScreenerStock ForecastHighest Earnings StocksBest Dividend Paying StocksStatisticsTrending Stocks
Analysts
Top Performing Analysts
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.